medigraphic.com
ISSN 0188-9796 (Print)

2009, Number 3

<< Back Next >>

Rev Endocrinol Nutr 2009; 17 (3)

Prognostic value of the clinical, biochemical and imaging characteristics of patients with non-functioning pituitary macroadenomas at diagnosis

López-Juárez N, Vargas G, Ramírez C, Cheng S, González B, Guinto-Balanzar G, Cohn-Zurita F, López-Félix B, Cabrera-Muñoz ML, Mercado M

Language: Spanish
References: 19
Page: 115-119
PDF size: 99.61 Kb.


ABSTRACT

Background and objective: Clinically non-functioning pituitary macroadenomas (NFPA) are the most common, and yet the least studied pituitary neoplasm. This study analyzes the baseline characteristics of a large group of patients with NFPA in an attempt to identify those features that may have a prognostic value. Material and methods: A database with the demographic, clinical, biochemical, imagenological and therapeutic characteristics of 312 patients with NFPA that attended the neuroendocrine clinic from March 2008 to June 2009 was created and analyzed. Results: The database included 173 men (55.4%) and 139 women (44.6%), with a mean age of 53.4 ± 13.7 years. The most common clinical presentations were: bitemporal hemianopsia (86.5%), headache (66%), pituitary apoplexy (6.7%) and oculo-motor palsies (6.1%); in 6.1% the finding was incidental. 48.4, 38.8 and 28.8% of the patients, had central hypothyroidism, hypogonadism and hypocortisolism, respectively; 20.2% had two or more hormonal deficiencies. Mean tumor volume was 14,248 ± 1,115 mm3. Pituitary surgery was the primary treatment in all cases; only 53 subjects were referred for radiotherapy. The recurrence rate after the first surgery was 33% after a mean follow up of 44± 39.25 months. Conclusion: None of the analyzed characteristics seemed to predict clinical/biological behavior of these tumors.


REFERENCES

  1. Dekkers OM, Pereira AM, Romijn JA.Treatment and follow-up of clinically non functioning pituitary macroadenomas. J Clin Endocrinol Metab 2008; 93: 3717-3726.

  2. Monson JP. The epidemiology of endocrine tumours. Endocr Rel Cancer 2000; 7: 29-36.

  3. Guinto-Balanzar G, López-Félix BE, Cohn-Zurita F, Pérez-Pérez VH, Nettel-Rueda B, Domínguez-Cortina F. Macroadenomas de hipófisis: Un reto neuroquirúrgico. Cirugía y Cirujanos 2003; 71: 350-358.

  4. Vlotides G, Eigler T, Melmed S. Pituitary tumor-transforming gene: Physiology and implications for tumorigenesis. Endocrine Reviews 2007; 28:165-186.

  5. Korbonits M, Carlsen E. Recent clinical and pathophysiological advances in non-functioning Pituitary adenomas. Horm Res 2009; 71(suppl 2): 123-130.

  6. Nawar NR, Abdal DA, Selman WR, Arafah BM. Pituitary tumor apoplexy: A review. Journal of Intensive Care Medicine 2008; 23: 75-90.

  7. Jane JE, Laws R. The management of non-functioning pituitary adenomas. Neurology India 2003; 51: 461-465.

  8. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998; 19: 798-827.

  9. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 2003; 112: 1603-1618.

  10. Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Amer 2008; 37; 151-171.

  11. Di Chiro G, Nelson KB. The volume of the sella Turcica. Am J Roentgenol Radium Ther Nucl Med 1962; 87: 989-1008.

  12. Esquenazi Y, Guinto G, Mercado M. El incidentaloma hipofisario. Gac Méd Méx 2008; 144: 550-554.

  13. Olavarría LC, Stott CC, Melchor LM et al. Comparación de dos técnicas quirúrgicas para el abordaje de la región selar: transeptal transesfenoidal vs transnasal directa. Rev Otorrinolaringol y Cir Cabeza Cuello 2004; 64: 91-98.

  14. Campero A. Macroadenomas de hipófisis con extensión supraselar: resultados quirúrgicos en 26 casos operados por vía endonasal transesfenoidal. Rev Arg Neurocir 2007; 21: 15-22.

  15. Jagannathan J, Kanter SA, Sheehan JP et al. Benign brain tumours: sellar/parasellar tumours. Neurol Clin 2007; 25: 1231–1249.

  16. Shimono T, Hiroto H, Kasagi K, Yuklo M, Nishizawa K, Misaki T, Hiraga A, Konishi J. Rapid progression of pituitary hyperplasia in primary hypothyroidism. Radiology 1999; 213: 383-388.

  17. Kaufman B, Kaufman BA, Baha´Uddin M et al. Large pituitary gland adenomas evaluated with magnetic resonance imaging. Neurosurgery 1987; 21: 415-418.

  18. Nelson PB, Goodman ML, Flickenger JC, Richardson DW, Robinson AG. Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy. Neurosurgery 1989; 24: 398-400.

  19. Tsang RW, Brierley JD, Panzarella T et al. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1994; 30: 557-565.




2020     |     www.medigraphic.com